30-Mar-16 E-commerce sales of Pfizer's health products are growing at more than 100% every year in China, the company says. It has been selling since 2012 through an official Tmall storefront, and also sells on JD.com and other online marketplaces including Yhd.com. [image: Alizila]
Read More
30-Mar-16 Major Malaysia pharma company Pharmaniaga Bhd expects its business in Indonesia to be profitable this year with a 1-2% growth in terms of contribution to its overall revenue. “In Indonesia currently, we have got common products manufactured there and we got high-end generic products in Malaysia, like cardiovascular products, that we can easily export,” managing director Datuk Farshila Emran said. [image: Pharmaniaga Bhd]
Read More
29-Mar-16 Obesity now afflicts over 56% of adults in Latin America, well above the global average of 34%. As a leading indicator of future health problems, the spread of obesity cannot go unmanaged. Addressing the overweight and obese populations of Latin America goes hand in hand with efforts to prevent chronic diseases. [image: Global Health Intelligence]
Read More
29-Mar-16 Malaysia's TMC Life Sciences Bhd is building a new hospital in Iskandar, and expanding its Kota Damansara hospital for a combined RM1.5 bn (USD384 mn). By 2019, beds at Kota Damansara will increase to 600. Iskandariah Hospital will provide 500 beds, which will also cater to patients from Singapore and Indonesia. TMC is targeting 25% revenue contribution from medical tourism by 2020. [image: TMC Life Sciences Bhd]
Read More
28-Mar-16 The National Healthcare Group has officially launched the inaugural Health Innovation Technology Challenge in Singapore, in search of apps that can be used to help patients and staff better understand illnesses and treatment. [image: Channel News Asia]
Read MoreGlobal Growth Markets is an intelligence, advisory and local execution firm helping clients identify opportunities, secure capital and grow their business.
We believe the only way to understand a market properly is on the ground. Our in-country experts, combined with AI-optimized analysis, give you a competitive advantage in over 40 markets across the Americas, EMEA and Asia-Pacific.
Our clients benefit from strategic insights, reduced risk and operational support, giving them the confidence to succeed in their global growth markets.
Value for money – real results at affordable rates
Work led by senior directors with >20 years track record
In-country presence across the Americas, EMEA and Asia-Pacific
Investor and private capital network built over decades
Proven frameworks for reliable insights and pragmatic advice
Boots on the ground supporting local execution
Find out more about our intelligence, advisory and execution services
Get in touch to discuss your growth markets needs:
Email: info@ggmkts.com
Follow us: